Molecular determinants of response of tumor cells to berberine

Cancer Genomics and Proteomics

Volumn 2, Issue 2, 2005, Pages 115-123

  Efferth, Thomas ^a   Chen, Zhongping ^b   Kaina, Bernd ^c   Wang, Gan ^d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b SUN YAT SEN UNIVERSITY   (China)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

ABC transporters; Berberine; Cluster analysis; DNA repair; Microarray analysis; Multidrug resistance

Indexed keywords

ABC TRANSPORTER; BERBERINE; BISANTRENE; CAMPTOTHECIN; CARBOPLATIN; CHROMOMYCIN; CISPLATIN; CYTOSTATIC AGENT; DACTINOMYCIN; DAUNORUBICIN; DIDEMNIN B; ETOPOSIDE; FLUOROURACIL; GELDANAMYCIN; IFOSFAMIDE; MAYTANSINE; MELPHALAN; MESSENGER RNA; METHOTREXATE; PACLITAXEL; PHYLLANTHOSIDE; PLATINUM DERIVATIVE; RHIZOXIN; TETROCARCIN A; TOPOTECAN; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; CELL DEATH; CELL PROLIFERATION; CROSS RESISTANCE; DRUG CYTOTOXICITY; GENE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYDRASTIS; IC 50; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PHENOTYPE; RNA SEQUENCE; TREATMENT OUTCOME; TUMOR CELL;

EID: 20344396408     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Tang W, Hemm I and Bertram B: Recent development of antitumor agents from Chinese herbal medicines; part I. Low molecular compounds. Planta Med 69: 97-108, 2003.
2. Tang W, Hemm I and Bertram B: Recent development of antitumor agents from Chinese herbal medicines. Part II. High molecular compounds(3). Planta Med 69: 193-201, 2003.
3. Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, Hengstler JG, Halatsch ME, Volm M, Tew KD, Ross DD and Funk JO: Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64: 382-394, 2003.
4. Efferth T, Sauerbrey A, Halatsch ME, Ross DD and Gebhart E: Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines. Naunyn Schmiedebergs Arch Pharmacol 367: 56-67, 2003.
5. Efferth T, Ramirez T, Gebhart E and Halatsch ME: Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774. Biochem Pharmacol 67: 1689-1700, 2004.
6. Efferth T and Oesch F: Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines. Biochem Pharmacol 68: 3-10, 2004.
7. Efferth T, Benakis A, Romero MR, Tomicic M, Rauh R, Steinbach D, Hafer R, Stamminger T, Oesch F, Kaina B and Marschall M: Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med 37: 998-1009, 2004.
8. Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E and Davey R: Activity of drugs from Traditional Chinese Medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol Dis 28: 160-168, 2002.
9. Birdsall TC and Kelly GS: Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Alt Med Res 2: 94-103, 1997.
10. Simeon S, Rios JL and Villar A: Pharmacological activities of proto-berberine alkaloids. Planta Med Phytother 23: 202-250, 1989.
11. Lau CW, Yao YQ, Chen ZY, Ko WH and Huang Y: Cardiovascular actions of berberine. Cardiovasc Drug Rev 19: 234-244, 2001.
12. Drewes SE, George J and Khan F: Recent findings on natural products with erectile-dysfunction activity. Phytochemistry 62: 1019-1025, 2003.
13. Rabbani GH, Butler T, Knight J, Sanyal SC and Alam K: Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 755: 979-984, 1987.
14. Kimmig A, Gekeler V, Neumann M, Frese G, Handgretinger R, Kardos G, Diddens H and Niethammer D: Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res 50: 6793-6799,1990.
15. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH and Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601, 1988.
16. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A and Boyd MR: Comparison of in vitro anticancer-drug- screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 82: 1113-1118, 1990.
17. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN: A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244, 2000.
18. Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, Mesirov JP, Lander ES and Golub TR: Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA 98: 10787-10792, 2001.
19. Wosikowski K, Schuurhuis D, Johnson K, Paull KD, Myers TG, Weinstein JN and Bates SE: Identification of epidermal growth factor receptor and erbB2 pathway inhibitors by correlation with gene expression patterns. J Natl Cancer Inst 89: 1505-1515, 1997.
20. Szakacs G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD, Reimers M, Weinstein JN and Gottesman MM: Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6: 129-137, 2004.
21. Hochberg Y and Benjamini Y: More powerful procedures for multiple significance testing. Stat Med 9: 811-818, 1990.
22. Reiner A, Yekutieli D and Benjamini Y: Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375, 2003.
23. Efferth T, Fabry U and Osieka R: Apoptosis and resistance to daunorubicin in human leukemic cells. Leukemia 11: 1180-1186, 1997.
24. de Bruijn MH, Van der Bliek AM, Biedler JL and Borst P: Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines. Mol Cell Biol 6: 4717-4722, 1986.
25. Cole SP: Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line. Cancer Chemother Pharmacol 26: 250-256, 1990.
26. Benchekroun MN, Schneider E, Safa AR, Townsend AJ and Sinha BK: Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Mol Pharmacol 46: 677-684, 1994.
27. Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT and Bates SE: Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol 46: 627-638, 1994.
28. Gupta RS, Murray W and Gupta R: Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line. Br J Cancer 58: 441-447, 1988.
29. van Ark-Otte J, Samelis G, Rubio G, Lopez Saez JB, Pinedo HM and Giaccone G: Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes. Oncol Rep 5: 249-255, 1998.
30. Rocchi E, Vigo J, Viallet P, Bonnard I and Salmon JM: Multiwavelength videomicrofluorometric study of cytotoxic effects of a marine peptide, didemnin B, on normal and MDR resistant CCRF-CEM cell lines. Anticancer Res 20: 987-996, 2000.
31. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
32. Gillet JP, Efferth T, Steinbach D, Hamels J, de Longueville F, Bertholet V and Remacle J: Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res 64: 8987-8993, 2004.
33. Lin HL, Liu TY, Wu CW and Chi CW: Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to paclitaxel. Br J Cancer 81: 416-422, 1999.
34. Pan GY, Wang GJ, Liu XD, Fawcett JP and Xie YY: The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 91: 193-197, 2002.
35. Amin AH, Subbaiah TV and Abbasi KM: Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol 75: 1067-1076, 1969.
36. Cushman M, Dekow FW and Jacobsen LB: Conformations, DNA binding parameters, and antileukemic activity of certain cytotoxic protoberberine alkaloids. J Med Chem 22: 331-333, 1979.
37. Ghosh AK, Bhattacharyya FK and Ghosh DK: Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp Parasitol 60: 404-413, 1985.
38. Sun D, Courtney HS and Beachey EH: Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimicrob Agents Chemother 32: 1370-1374, 1988.
39. Lesnau A, Hils J, Pohl G, Beyer G, Janka M and Hoa LT: Antiviral activity of berberine salts [Article in German]. Pharmazie 45: 638-639, 1990.
40. Nakamoto K, Sadamori S and Hamada T: Effects of crude drugs and berberine hydrochloride on the activities of fungi. J Prosthet Dent 64: 691-694, 1990.
41. Shitan N, Bazin I, Dan K, Obata K, Kigawa K, Ueda K, Sato F, Forestier C and Yazaki K: Involvement of CjMDR1, a plant multidrug-resistance-type ATP-binding cassette protein, in alkaloid transport in Coptis japonica. Proc Natl Acad Sci USA 700: 751-756, 2003.
42. Nikaido H: Microdermatology: cell surface in the interaction of microbes with the external world. J Bacteriol 181: 4-8, 1999.
43. Tegos G, Stermitz FR, Lomovskaya O and Lewis K: Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother 46: 3133-3141, 2002.
44. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA and Lewis K: Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 97: 1433-1437, 2000.
45. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S and Fujiwara H: Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med 65: 381-383, 1999.
46. Wu HL, Hsu CY, Liu WH and Yung BY: Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 81: 923-929, 1999.
47. Kang MR and Chung IK: Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine. Mol Pharmacol 61: 879-884, 2002.
48. Iizuka N, Oka M, Yamamoto K, Tangoku A, Miyamoto K, Miyamoto T, Uchimura S, Hamamoto Y and Okita K: Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int J Cancer 707: 666-672, 2003.